• Singapore’s Temasek is one of several government funds to go beyond their traditional mandate and fight the pandemic, not just by investing in the search for a vaccine, but also by supporting the production of medical goods
  • As Hong Kong prepares to launch its own Growth Portfolio, it needs to consider if there’s a larger firefighting role for public investors in a crisis